nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

15.04.2020 | Editorial

Toward understanding the 2019 Coronavirus and its impact on the heart

verfasst von: Richard C. Becker

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

The purpose of human life is to serve, and to show compassion and the will to help others.

Albert Schweitzer

…

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China. Lancet 395:497–506CrossRefPubMedPubMedCentral

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W (2020) A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733CrossRefPubMedPubMedCentral

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK (2020) First case of 2019 novel Coronavirus in the United States. N Engl J Med 382:929–936CrossRefPubMedPubMedCentral

Ceraolo C, Giorgi FM (2020) Genomic variance of the 2019-nCoV Coronavirus. J Med Virol 92:522–528CrossRefPubMedPubMedCentral

Sah R, Rodriguez-Morales AJ, Jha R, Chu DKW, Gu H, Peiris M, Bastola A, Lal BK, Ojha HC, Rabaan AA, Zambrano LI, Costello A, Morita K, Pandey BD, Poon LLM (2020) Complete genome sequence of a 2019 novel Coronavirus (SARS-CoV-2) strain isolated in Nepal. Microbiol Resour Announc. https://doi.org/10.1128/MRA.00169-20 CrossRefPubMedPubMedCentral

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ (2020) A new Coronavirus associated with human respiratory disease in China. Nature 579:265–269CrossRefPubMedPubMedCentral

Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, Queen K, Tao Y, Paden CR, Zhang J, Li Y, Uehara A, Wang H, Goldsmith C, Bullock HA, Wang L, Whitaker B, Lynch B, Gautam R, Schindewolf C, Lokugamage KG, Scharton D, Plante JA, Mirchandani D, Widen SG, Narayanan K, Makino S, Ksiazek TG, Plante KS, Weaver SC, Lindstrom S, Tong S, Menachery VD, Thornburg NJ (2020) Severe acute respiratory syndrome Coronavirus 2 from patient with 2019 novel Coronavirus disease, United States. Emerg Infect Dis. https://doi.org/10.3201/eid2606.200516 CrossRefPubMedPubMedCentral

Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, Li L, He R, Tan Y, Deng X, Gao M, Tang G, Zhao L, Wang J, Fan Q, Wen C, Tong Y, Tang Y, Hu F, Li F, Tang X (2020) Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microb Infect 9:469–473CrossRef

Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. https://doi.org/10.1016/j.cell.2020.02.058 CrossRefPubMedPubMedCentral

10.

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367:1260–1263CrossRefPubMedPubMedCentral

11.

Chen Y, Liu Q, Guo D (2020) Emerging Coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418–423CrossRefPubMedPubMedCentral

12.

Fung TS, Liu DX (2019) Human Coronavirus: host-pathogen interaction. Annu Rev Microbiol 73:529–557CrossRefPubMed

13.

Song W, Gui M, Wang X, Xiang Y (2018) Cryo-EM structure of the SARS Coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog 14:e1007236CrossRefPubMedPubMedCentral

14.

Li C, Yang Y, Ren L (2020) Genetic evolution analysis of 2019 novel Coronavirus and Coronavirus from other species. Infect Genet Evol: J Mol Epidemiol Evol Genet Infect Dis 82:104285CrossRef

15.

Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, Zhou Z, Yang J, Zhong J, Yang D, Guo L, Zhang G, Li H, Xu Y, Chen M, Gao Z, Wang J, Ren L, Li M (2020) Genomic diversity of SARS-CoV-2 in Coronavirus disease 2019 patients. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa203/5780800 CrossRefPubMedPubMedCentral

16.

Tang JW, Tambyah PA, Hui DSC (2020) Emergence of a novel Coronavirus causing respiratory illness from Wuhan, China. J Infect 80:350–371CrossRefPubMedPubMedCentral

17.

Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel Coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS Coronavirus. J Virol. https://doi.org/10.1128/JVI.00127-20 CrossRefPubMedPubMedCentral

18.

Tang X, Wu C, Li X, Song Y, Yao X, Wu X, Duan Y, Zhang H, Wang Y, Qian Z, Cui J, Lu J (2020) On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. https://doi.org/10.1093/nsr/nwaa036/5775463 CrossRefPubMedCentralPubMed

19.

Liu Q, Zhou YH, Yang ZQ (2016) The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol 13:3–10CrossRefPubMed

20.

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J (2020) SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 382:1177–1179CrossRefPubMedPubMedCentral

21.

Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. https://doi.org/10.1007/s11684-020-0754-0 CrossRefPubMedPubMedCentral

22.

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS Coronavirus A first step in understanding SARS pathogenesis. J Pathol 203:631–637CrossRefPubMedPubMedCentral

23.

Qi F, Qian S, Zhang S, Zhang Z (2020) Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human Coronaviruses. Biochem Biophys Res Commun. https://doi.org/10.1016/j.bbrc.2020.03.044 CrossRefPubMedPubMedCentral

24.

Pasanen L, Launonen H, Siltari A, Korpela R, Vapaatalo H, Salmenkari H, Forsgard RA (2019) Age-related changes in the local intestinal renin-angiotensin system in normotensive and spontaneously hypertensive rats. J Physiol Pharmacol. https://doi.org/10.26402/jpp.2019.2.03.pdf CrossRefPubMed

25.

Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel Coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820CrossRefPubMed

26.

Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF, Makhdoom HQ, Zumla AI, Memish ZA (2013) Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome Coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13:752–761CrossRefPubMedPubMedCentral

27.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y (2020) Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01626-9 CrossRefPubMedPubMedCentral

28.

Fu Y, Cheng Y, Wu Y (2020) Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. https://doi.org/10.1007/s12250-020-00207-4 CrossRefPubMedPubMedCentral

29.

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63:364–374CrossRefPubMedPubMedCentral

30.

Leung C (2020) Clinical features of deaths in the novel Coronavirus epidemic in China. Rev Med Virol. https://doi.org/10.1002/rmv.2103 CrossRefPubMedPubMedCentral

31.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020) A pneumonia outbreak associated with a new Coronavirus of probable bat origin. Nature 579:270–273CrossRefPubMedPubMedCentral

32.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585 CrossRefPubMedPubMedCentral

33.

Chen C, Zhou Y, Wang DW (2020) SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. https://doi.org/10.1007/s00059-020-04909-z CrossRefPubMedPubMedCentral

34.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5 CrossRefPubMedPubMedCentral

35.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.0950 CrossRefPubMedPubMedCentral

36.

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020) Epidemiological characteristics of 2143 pediatric patients with 2019 Coronavirus disease in China. Pediatrics. https://doi.org/10.1542/peds.2020-0702 CrossRefPubMedPubMedCentral

37.

Zheng F, Liao C, Fan QH, Chen HB, Zhao XG, Xie ZG, Li XL, Chen CX, Lu XX, Liu ZS, Lu W, Chen CB, Jiao R, Zhang AM, Wang JT, Ding XW, Zeng YG, Cheng LP, Huang QF, Wu J, Luo XC, Wang ZJ, Zhong YY, Bai Y, Wu XY, Jin RM (2020) Clinical characteristics of children with Coronavirus disease 2019 in Hubei, China. Curr Med Sci. https://doi.org/10.1007/s11596-020-2172-6 CrossRefPubMedPubMedCentral

38.

Li Y, Guo F, Cao Y, Li L, Guo Y (2020) Insight into COVID-2019 for pediatricians. Pediatr Pulmonol. https://doi.org/10.1002/ppul.24734 CrossRefPubMedPubMedCentral

39.

Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D (2020) Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol. https://doi.org/10.1002/ppul.24718 CrossRefPubMedPubMedCentral

40.

Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, Zheng Y, Xu B, Xie Z, Lin L, Shang Y, Lu X, Shu S, Bai Y, Deng J, Lu M, Ye L, Wang X, Wang Y, Gao L (2020) Diagnosis, treatment, and prevention of 2019 novel Coronavirus infection in children: experts’ consensus statement. WJP. https://doi.org/10.1007/s12519-020-00343-7 CrossRefPubMed

41.

Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, Xia S, Zhou W (2020) Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 9:51–60CrossRefPubMedPubMedCentral

42.

Patel AB, Verma A (2020) COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA. https://doi.org/10.1001/jama.2020.4812 CrossRefPubMedPubMedCentral

43.

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C (2020) A Trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282 CrossRefPubMedPubMedCentral

44.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel Coronavirus (2019-nCoV) in vitro. Cell Res 30:269–271CrossRefPubMedPubMedCentral

45.

Zhang L, Liu Y (2020) Potential interventions for novel Coronavirus in China: a systematic review. J Med Virol 92:479–490CrossRefPubMedPubMedCentral

46.

Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W (2020) Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol 38:10–18PubMed

47.

Yuan Y, Cao D, Zhang Y, Ma J, Qi J, Wang Q, Lu G, Wu Y, Yan J, Shi Y, Zhang X, Gao GF (2017) Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun 8:15092CrossRefPubMedPubMedCentral

48.

Ahmed SF, Quadeer AA, McKay MR (2020) Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses 12:254CrossRefPubMedCentral

49.

Chen WH, Chag SM, Poongavanam MV, Biter AB, Ewere EA, Rezende W, Seid CA, Hudspeth EM, Pollet J, McAtee CP, Strych U, Bottazzi ME, Hotez PJ (2017) Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate. J Pharm Sci 106:1961–1970CrossRefPubMedPubMedCentral

50.

Jiang S, Bottazzi ME, Du L, Lustigman S, Tseng CT, Curti E, Jones K, Zhan B, Hotez PJ (2012) Roadmap to developing a recombinant Coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome. Expert Rev Vaccines 11:1405–1413CrossRefPubMed

51.

Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, Lam YM, Chan C, Tsang TC, Tsui M, Tse HF, Siu CW (2020) Impact of Coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. https://doi.org/10.1161/CIRCOUTCOMES.120.006631 CrossRefPubMedPubMedCentral

Titel: Toward understanding the 2019 Coronavirus and its impact on the heart
verfasst von: Richard C. Becker
Publikationsdatum: 15.04.2020
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 1/2020
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02107-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Acute pulmonary embolism in COVID-19 related hypercoagulability

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors

Reducing state attenuates ectodomain shedding of GPVI while restoring adhesion capacities of stored platelets: evidence addressing the controversy around the effects of redox condition on thrombosis

Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report

Characterization of circulating thrombin in patients with septic shock: a prospective observational study